Relationships Between Sensorimotor Inhibition and Mobility in Older Adults With and Without Parkinson's Disease

被引:10
作者
Martini, Douglas N. [1 ,2 ]
Morris, Rosie [1 ]
Madhyastha, Tara M. [3 ]
Grabowski, Thomas J. [3 ]
Oakley, John [4 ]
Hu, Shu-Ching [4 ,5 ]
Zabetian, Cyrus P. [4 ,5 ]
Edwards, Karen L. [6 ]
Hiller, Amie [1 ,7 ]
Chung, Kathryn [1 ,7 ]
Ramsey, Katrina [8 ]
Lapidus, Jodi A. [8 ,9 ]
Cholerton, Brenna [10 ]
Montine, Thomas J. [10 ]
Quinn, Joseph F. [1 ,7 ]
Horak, Fay B. [1 ,7 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
[2] Univ Massachusetts, Dept Kinesiol, 30 Eastman Lane, Amherst, MA 01003 USA
[3] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA
[5] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA
[6] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA
[7] Portland Vet Affairs Hlth Care Syst, Portland, OR USA
[8] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA
[9] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
[10] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2021年 / 76卷 / 04期
关键词
Cognition; Gait; Short-latency afferent inhibition; Transcranial magnetic stimulation; LATENCY AFFERENT INHIBITION; MILD COGNITIVE IMPAIRMENT; PHARMACOLOGICAL-TREATMENT; CHOLINERGIC DYSFUNCTION; GAIT VARIABILITY; DUAL TASKING; DOPAMINE; LEVODOPA; BALANCE; PEOPLE;
D O I
10.1093/gerona/glaa300
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Reduced cortical sensorimotor inhibition is associated with mobility and cognitive impairments in people with Parkinson's disease (PD) and older adults (OAs). However, there is a lack of clarity regarding the relationships among sensorimotor, cognitive, and mobility impairments. The purpose of this study was to determine how cortical sensorimotor inhibition relates to impairments in mobility and cognition in people with PD and OAs. Method: Cortical sensorimotor inhibition was characterized with short-latency afferent inhibition (SAI) in 81 people with PD and 69 OAs. Six inertial sensors recorded single- and dual-task gait and postural sway characteristics during a 2-minute walk and a 1-minute quiet stance. Cognition was assessed across the memory, visuospatial, executive function, attention, and language domains. Results: SAI was significantly impaired in the PD compared to the OA group. The PD group preformed significantly worse across all gait and postural sway tasks. In PD, SAI significantly correlated with single-task foot strike angle and stride length variability, sway area, and jerkiness of sway in the coronal and sagittal planes. In OAs, SAI significantly related to single-task gait speed and stride length, dual-task stride length, and immediate recall (memory domain). No relationship among mobility, cognition, and SAI was observed. Conclusions: Impaired SAI related to slower gait in OA and to increased gait variability and postural sway in people with PD, all of which have been shown to be related to increased fall risk.
引用
收藏
页码:630 / 637
页数:8
相关论文
共 41 条
  • [1] Neurotransmission in Parkinson's disease: beyond dopamine
    Barone, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) : 364 - 376
  • [2] Prospective assessment of falls in Parkinson's disease
    Bloem, BR
    Grimbergen, YAM
    Cramer, M
    Willemsen, M
    Zwinderman, AH
    [J]. JOURNAL OF NEUROLOGY, 2001, 248 (11) : 950 - 958
  • [3] Gait speed in Parkinson disease correlates with cholinergic degeneration
    Bohnen, Nicolaas I.
    Frey, Kirk A.
    Studenski, Stephanie
    Kotagal, Vikas
    Koeppe, Robert A.
    Scott, Peter J. H.
    Albin, Roger L.
    Mueller, Martijn L. T. M.
    [J]. NEUROLOGY, 2013, 81 (18) : 1611 - 1616
  • [4] Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
    Brichta, Lars
    Greengard, Paul
    Flajolet, Marc
    [J]. TRENDS IN NEUROSCIENCES, 2013, 36 (09) : 543 - 554
  • [5] Pacific Northwest Udall Center of Excellence Clinical Consortium: Study Design and Baseline Cohort Characteristics
    Cholerton, Brenna A.
    Zabetian, Cyrus P.
    Quinn, Joseph F.
    Chung, Kathryn A.
    Peterson, Amie
    Espay, Alberto J.
    Revilla, Fredy J.
    Devoto, Johnna
    Watson, G. Stennis
    Hu, Shu-Ching
    Edwards, Karen L.
    Montine, Thomas J.
    Leverenz, James B.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2013, 3 (02) : 205 - 214
  • [6] Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease
    Curtze, Carolin
    Nutt, John G.
    Carlson-Kuhta, Patricia
    Mancini, Martina
    Horak, Fay B.
    [J]. MOVEMENT DISORDERS, 2015, 30 (10) : 1361 - 1370
  • [7] In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias
    Di Lazzaro, V
    Pilato, F
    Dileone, M
    Saturno, E
    Oliviero, A
    Marra, C
    Daniele, A
    Ranieri, F
    Gainotti, G
    Tonali, PA
    [J]. NEUROLOGY, 2006, 66 (07) : 1111 - 1113
  • [8] Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans
    Di Lazzaro, V
    Oliviero, A
    Saturno, E
    Dileone, M
    Pilato, F
    Nardone, R
    Ranieri, F
    Musumeci, G
    Fiorilla, T
    Tonali, P
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2005, 564 (02): : 661 - 668
  • [9] Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex
    Di Lazzaro, V
    Oliviero, A
    Profice, P
    Pennisi, MA
    Di Giovanni, S
    Zito, G
    Tonali, P
    Rothwell, JC
    [J]. EXPERIMENTAL BRAIN RESEARCH, 2000, 135 (04) : 455 - 461
  • [10] Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges
    Francisco Martin-Rodriguez, Juan
    Mir, Pablo
    [J]. NEUROSCIENCE LETTERS, 2020, 719